Home › Calculator › HNGZY Dividend Calculator 2026
HNGZY DRIP Calculator & Dividend Yield 2026
0.29% YieldHealthcareHangzhou Tigermed Consulting Co., Ltd · OTC
Price: $4.45 · Annual div: $0.0130/share · Frequency: annual · Payout ratio: 1% · Ex-div: 2026-06-22
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
HNGZY Dividend Yield
HNGZY (Hangzhou Tigermed Consulting Co., Ltd) has a dividend yield of 0.29%, based on an annual dividend of $0.0130 per share and a price of $4.45. Over the last 12 months it paid $0.0130 per share — a trailing yield of 0.29%. Dividends are paid annual.
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When HNGZY pays your bills
Year your monthly dividend income covers each expense (based on current settings)
HNGZY Dividend History — Last 4 Payments
| Ex-Dividend Date | Payment Date | Amount / Share | TTM Yield | Stock Price |
|---|---|---|---|---|
| 2026-06-22Latest | 2026-08-05 | $0.0130 | 0.32% | $4.00 |
| 2025-06-13 | 2025-08-14 | $0.0290 | 0.72% | $4.00 |
| 2024-06-11 | 2024-08-01 | $0.0559 | 1.33% | $4.20 |
| 2023-05-25 | 2023-07-21 | $0.0550 | 0.48% | $11.50 |
About Hangzhou Tigermed Consulting Co., Ltd (HNGZY) — Dividend Analysis 2026
Hangzhou Tigermed Consulting Co., Ltd, together with its subsidiaries, provides contract research organization services in the People's Republic of China and internationally. The company offers clinical trial operation services, such as clinical pharmacology, registration and regulatory affairs, scientific affairs, medical translation, pharmacovigilance, real-world research, third-party auditing and training, etc. for innovative drugs, generic drugs, and medical devices, as well as supporting services directly related to clinical trials, including clinical operation, clinical trials, and clinical trials management. It also provides clinical trial related and laboratory services in the drug development process comprising data management and statistical analysis, clinical trial site management, subject recruitment, medical imaging, and laboratory services. In addition, the company offers preclinical development services, including medicinal chemistry, compound screening, DMPK, safety and toxicology, bioanalytical, and formulation research and development services; and clinical development services, such as medical writing, clinical monitoring, regulatory affairs, data management and statistical analysis, decentralized clinical trials, clinical development strategy, site management, medical device/in vitro diagnostics, multi-region clinical trial, and vaccine clinical trial services. Further, it provides medical imaging, pharmacovigilance, medical translation, quality assurance, GMP and medical device consulting, central laboratories, functional services, recruitment management, EDC cloud-based system, and remote follow-up center services; and post-marketing clinical research solutions, such as site identification and selection, central monitoring, project team management, vendor management, and SAS project management services. Hangzhou Tigermed Consulting Co., Ltd was incorporated in 2004 and is headquartered in Hangzhou, the People's Republic of China.
Similar dividend stocks to HNGZY
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full HNGZY DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open HNGZY position with:
🌍 HNGZY Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold HNGZY.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.29% | -2.51% | $29 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.25% | -2.55% | $25 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.23% | -2.57% | $23 / yr |
| 🇬🇧 UK ISA | 0% | 0.29% | -2.51% | $29 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.26% | -2.54% | $26 / yr |
| 🇨🇦 TFSA | 0% | 0.29% | -2.51% | $29 / yr |
| 🇨🇦 CA Taxable | 25% | 0.22% | -2.58% | $22 / yr |
| 🇦🇺 Super (pension) | 15% | 0.25% | -2.55% | $25 / yr |
| 🇦🇺 AU Taxable | 30% | 0.20% | -2.60% | $20 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.21% | -2.59% | $21 / yr |
| 🇫🇷 FR Taxable | 30% | 0.20% | -2.60% | $20 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 HNGZY Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $0.01/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 HNGZY Dividend Payment Schedule
HNGZY pays annually — 1 payment per year.
📊 HNGZY vs Healthcare Benchmarks
How HNGZY compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for HNGZY sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ HNGZY Insider Activity
No recent SEC filings reported in the last 90 days.Peer Group
Similar companies in the same sectorCompare HNGZY with peers: HNGZY vs QUCY · HNGZY vs RVTY · HNGZY vs SHPMY
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the HNGZY dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Hangzhou Tigermed Consulting Co., Ltd (HNGZY) is currently trading at $4.45, trading near its 52-week high. The current dividend yield is 0.29% based on an annual payout of $0.0130 per share.
HNGZY (Hangzhou Tigermed Consulting Co., Ltd) — 0.29% Dividend Yield Analysis
Hangzhou Tigermed Consulting Co., Ltd (HNGZY) is a healthcare stock currently trading at $4.45 with a dividend yield of 0.29%. It pays an annual dividend of $0.0130 per share. The payout ratio of 1% suggests the dividend is well-covered by earnings. Over the past 5 years, HNGZY has grown its dividend at a compound annual rate of 9.0%.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest HNGZY News
LiveHow investors use the HNGZY dividend calculator
Illustrative examples of common use cases, written by the DividendFlow team — not customer reviews.